Impact of Gestational Diabetes Mellitus on Neonatal Birth Outcomes

Ying Liu1, Meixia Wang1, Jin Zhou2

  • 1Obstetrical Department VIII, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.

Aims/Background The purpose of this study is to investigate the risk factors for gestational diabetes mellitus (GDM) during pregnancy and its impact on neonatal birth outcomes. Methods A total of 2010 cases of mothers with GDM who underwent routine prenatal examinations and delivered at The Fourth Hospital of Shijiazhuang from June 2021 to April 2022, and their newborns were selected as the GDM group. For comparison, 2087 cases of mothers with normal glucose tolerance (NGT) and their newborns during the same period were selected as the NGT group. Birth outcomes of both groups were compared. Results Pregnant women in the GDM group exhibited significantly higher proportions of advanced age, higher body mass index (BMI), and irregular dietary habits compared to the NGT group (p < 0.05). Conversely, the GDM group had significantly lower proportions of nutrient supplementation and prenatal exercise compared to the NGT group (p < 0.05). The incidences of macrosomia, neonatal hypoglycemia, hyperbilirubinemia, and acute respiratory distress syndrome (ARDS) were significantly higher in the GDM group compared to the NGT group (p < 0.05 for all). Among GDM women with adverse outcomes, significant differences were observed in pre-pregnancy BMI, insufficient or excessive weight gain during pregnancy, and poor glycemic control during pregnancy compared to those without adverse outcomes (p < 0.05 for all). Poor glycemic control during pregnancy, pre-pregnancy BMI, and inadequate or excessive weight gain were significant factors influencing adverse pregnancy outcomes in GDM patients (p < 0.05). Conclusion The risk factors for GDM include advanced maternal age, being underweight, overweight, or obese prior to pregnancy, irregular eating habits, dietary nutritional deficiencies, and lack of prenatal exercise. The incidence of adverse pregnancy outcomes is higher in GDM patients compared to those without GDM. Poor glycemic control during pregnancy and higher pre-pregnancy BMI are significant factors that contribute to negative outcomes for both GDM patients and their newborns.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K